speb/financial-data huggingface dataset:
CCIX balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 10062500.00
CCIX income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -3938049.00
CCIX income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -400021.00
CCIX balance_sheet (annual, 2025-12-31) — Tradeand Other Payables Non Current: 10062500.00
CCIX balance_sheet (quarterly, 2025-12-31) — Tradeand Other Payables Non Current: 10062500.00
CCIX balance_sheet (annual, 2025-12-31) — Working Capital: -11266.00
CCIX balance_sheet (quarterly, 2025-12-31) — Working Capital: -11266.00
CCIX income_statement (quarterly, 2026-03-31) — +Operating Expense: 1153135.00
CCIX income_statement (quarterly, 2026-03-31) — +Total Revenue: 0.00
CCIX balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 0.00
CCIX income_statement (quarterly, 2026-03-31) — Basic Average Shares: 36662500.00
CCIX income_statement (quarterly, 2026-03-31) — Basic EPS: 0.04
CCIX cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 2469.00
CCIX balance_sheet (quarterly, 2026-03-31) — Capital Stock: 310265301.00
CCIX balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 167798.00
CCIX balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 167798.00
CCIX balance_sheet (quarterly, 2026-03-31) — Cash Financial: 167798.00
CCIX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 500000.00
CCIX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -334671.00
CCIX cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: 772181.00
CCIX cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 772181.00
CCIX cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 46283.00
CCIX cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 818464.00
CCIX cash_flow (quarterly, 2026-03-31) — Changes In Cash: 165329.00
CCIX balance_sheet (quarterly, 2026-03-31) — Common Stock: 310265301.00
CCIX balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 299037608.00
CCIX cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 500000.00
CCIX balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 945150.00
CCIX balance_sheet (quarterly, 2026-03-31) — Current Assets: 280749.00
CCIX balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 945150.00
CCIX income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 36662500.00
CCIX income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.04
CCIX income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 1493975.00
CCIX income_statement (quarterly, 2026-03-31) — EBIT: -1153135.00
CCIX income_statement (quarterly, 2026-03-31) — EBITDA: -1153135.00
CCIX cash_flow (quarterly, 2026-03-31) — End Cash Position: 167798.00
CCIX cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 500000.00
CCIX cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -334671.00
CCIX income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 1153135.00
CCIX income_statement (quarterly, 2026-03-31) — Interest Income: 2647110.00
CCIX income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 2647110.00
CCIX balance_sheet (quarterly, 2026-03-31) — Invested Capital: 299537608.00
CCIX cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 500000.00
CCIX balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 500000.00
CCIX balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 500000.00
CCIX cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 500000.00
CCIX balance_sheet (quarterly, 2026-03-31) — Net Debt: 332202.00
CCIX income_statement (quarterly, 2026-03-31) — Net Income: 1493975.00
CCIX income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 1493975.00
CCIX income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 1493975.00
CCIX income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 1493975.00
CCIX income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 1493975.00
CCIX cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 1493975.00
CCIX income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 1493975.00
CCIX income_statement (quarterly, 2026-03-31) — Net Interest Income: 2647110.00
CCIX income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 2647110.00
CCIX balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 299037608.00
CCIX income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -1153135.00
CCIX income_statement (quarterly, 2026-03-31) — Normalized Income: 1493975.00
CCIX cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -334671.00
CCIX income_statement (quarterly, 2026-03-31) — Operating Income: -1153135.00
CCIX income_statement (quarterly, 2026-03-31) — Operating Revenue: 0.00
CCIX balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 36662500.00
CCIX income_statement (quarterly, 2026-03-31) — Other Gand A: 1153135.00
CCIX cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -2647110.00
CCIX balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 310264509.00
CCIX balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 945150.00
CCIX balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
CCIX balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 112951.00
CCIX income_statement (quarterly, 2026-03-31) — Pretax Income: 1493975.00
CCIX balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -11227693.00
CCIX income_statement (quarterly, 2026-03-31) — Selling General And Administration: 1153135.00
CCIX balance_sheet (quarterly, 2026-03-31) — Share Issued: 36662500.00
CCIX balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 299037608.00
CCIX balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 299037608.00
CCIX income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
CCIX income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
CCIX balance_sheet (quarterly, 2026-03-31) — Total Assets: 310545258.00
CCIX balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 299537608.00
CCIX balance_sheet (quarterly, 2026-03-31) — Total Debt: 500000.00
CCIX balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 299037608.00
CCIX income_statement (quarterly, 2026-03-31) — Total Expenses: 1153135.00
CCIX balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 11507650.00
CCIX balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 310264509.00
CCIX balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 10562500.00
CCIX income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -1153135.00
CCIX balance_sheet (quarterly, 2026-03-31) — Tradeand Other Payables Non Current: 10062500.00
CCIX balance_sheet (quarterly, 2026-03-31) — Working Capital: -664401.00
CCJ balance_sheet (annual, 2021-12-31) — Investmentin Financial Assets: 577527000.00
CCJ balance_sheet (annual, 2021-12-31) — Investmentsin Associatesat Cost: 233240000.00
CCJ cash_flow (annual, 2021-12-31) — Net Business Purchase And Sale: 0.00
CCJ balance_sheet (annual, 2021-12-31) — Non Current Accounts Receivable: 577527000.00
CCJ income_statement (annual, 2021-12-31) — Other Non Operating Income Expenses: -302000.00
CCJ cash_flow (annual, 2021-12-31) — Proceeds From Stock Option Exercised: 26771000.00
CCJ cash_flow (annual, 2021-12-31) — Provisionand Write Offof Assets: -8407000.00
CCJ cash_flow (annual, 2021-12-31) — Purchase Of Business: 0.00
CCJ cash_flow (annual, 2021-12-31) — Purchase Of Investment: -59921000.00
CCJ balance_sheet (annual, 2021-12-31) — Restricted Cash: 233257000.00
CCJ income_statement (annual, 2021-12-31) — Restructuring And Mergern Acquisition: 0.00
CCJ income_statement (annual, 2022-12-31) — +Operating Expense: 217726000.00
CCJ income_statement (annual, 2022-12-31) — +Total Revenue: 1868003000.00
CCJ balance_sheet (annual, 2022-12-31) — Accounts Payable: 249962000.00
CCJ balance_sheet (annual, 2022-12-31) — Accounts Receivable: 167688000.00
CCJ balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -5952313000.00
CCJ balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 224687000.00
CCJ income_statement (annual, 2022-12-31) — Basic Average Shares: 405494353.00
CCJ income_statement (annual, 2022-12-31) — Basic EPS: 0.22
CCJ cash_flow (annual, 2022-12-31) — Beginning Cash Position: 1247447000.00
CCJ cash_flow (annual, 2022-12-31) — Capital Expenditure: -143448000.00
CCJ balance_sheet (annual, 2022-12-31) — Capital Stock: 2880336000.00
CCJ balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 1143674000.00
CCJ balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 2281848000.00
CCJ cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -51895000.00
CCJ cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 869258000.00
CCJ cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -1290822000.00
CCJ cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 304607000.00
CCJ cash_flow (annual, 2022-12-31) — Change In Inventory: -226358000.00
CCJ cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 16401000.00
CCJ cash_flow (annual, 2022-12-31) — Change In Receivables: 99601000.00
CCJ cash_flow (annual, 2022-12-31) — Change In Working Capital: -110356000.00
CCJ cash_flow (annual, 2022-12-31) — Changes In Account Receivables: 99601000.00
CCJ cash_flow (annual, 2022-12-31) — Changes In Cash: -116957000.00
CCJ balance_sheet (annual, 2022-12-31) — Common Stock: 2880336000.00
CCJ cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -51895000.00
CCJ balance_sheet (annual, 2022-12-31) — Common Stock Equity: 5836054000.00
CCJ cash_flow (annual, 2022-12-31) — Common Stock Issuance: 962917000.00
CCJ balance_sheet (annual, 2022-12-31) — Construction In Progress: 234590000.00
CCJ income_statement (annual, 2022-12-31) — Cost Of Revenue: 1634712000.00
CCJ balance_sheet (annual, 2022-12-31) — Current Assets: 3321636000.00
CCJ balance_sheet (annual, 2022-12-31) — Current Liabilities: 560841000.00
CCJ balance_sheet (annual, 2022-12-31) — Current Provisions: 48305000.00
CCJ cash_flow (annual, 2022-12-31) — Deferred Income Tax: -4469000.00
CCJ cash_flow (annual, 2022-12-31) — Deferred Tax: -4469000.00
CCJ cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 177376000.00
CCJ cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 177376000.00
CCJ income_statement (annual, 2022-12-31) — Diluted Average Shares: 407135000.00
CCJ income_statement (annual, 2022-12-31) — Diluted EPS: 0.22
CCJ income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 89382000.00
CCJ cash_flow (annual, 2022-12-31) — Dividend Received Cfo: 117698000.00
CCJ balance_sheet (annual, 2022-12-31) — Dueto Related Parties Current: 59570000.00
CCJ income_statement (annual, 2022-12-31) — EBIT: 153833000.00
CCJ income_statement (annual, 2022-12-31) — EBITDA: 331209000.00
CCJ income_statement (annual, 2022-12-31) — Earnings From Equity Interest: 93988000.00
CCJ cash_flow (annual, 2022-12-31) — Earnings Losses From Equity Investments: -93988000.00
CCJ cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 13184000.00
CCJ cash_flow (annual, 2022-12-31) — End Cash Position: 1143674000.00
CCJ cash_flow (annual, 2022-12-31) — Financing Cash Flow: 869258000.00
CCJ balance_sheet (annual, 2022-12-31) — Finished Goods: 80144000.00
CCJ cash_flow (annual, 2022-12-31) — Free Cash Flow: 161159000.00
CCJ cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 82636000.00
CCJ income_statement (annual, 2022-12-31) — Gain On Sale Of Ppe: -514000.00
CCJ income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 1183000.00
CCJ income_statement (annual, 2022-12-31) — General And Administrative Expense: 172029000.00
CCJ balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 47117000.00
CCJ balance_sheet (annual, 2022-12-31) — Gross PPE: 9425803000.00
CCJ income_statement (annual, 2022-12-31) — Gross Profit: 233291000.00
CCJ income_statement (annual, 2022-12-31) — Interest Expense: 69038000.00
CCJ income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 69038000.00
CCJ income_statement (annual, 2022-12-31) — Interest Income: 37499000.00
CCJ income_statement (annual, 2022-12-31) — Interest Income Non Operating: 37499000.00
CCJ cash_flow (annual, 2022-12-31) — Interest Paid Cff: -38856000.00
CCJ cash_flow (annual, 2022-12-31) — Interest Received Cfo: 35443000.00
CCJ balance_sheet (annual, 2022-12-31) — Inventory: 822608000.00
CCJ balance_sheet (annual, 2022-12-31) — Invested Capital: 6833054000.00
CCJ cash_flow (annual, 2022-12-31) — Investing Cash Flow: -1290822000.00
CCJ balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 595507000.00
CCJ balance_sheet (annual, 2022-12-31) — Investments And Advances: 210972000.00
CCJ balance_sheet (annual, 2022-12-31) — Investmentsin Associatesat Cost: 210972000.00
CCJ balance_sheet (annual, 2022-12-31) — Investmentsin Joint Venturesat Cost: 0.00
CCJ cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 962917000.00
CCJ cash_flow (annual, 2022-12-31) — Issuance Of Debt: 0.00
CCJ balance_sheet (annual, 2022-12-31) — Land And Improvements: 5197138000.00
CCJ balance_sheet (annual, 2022-12-31) — Leases: 5959000.00
CCJ balance_sheet (annual, 2022-12-31) — Long Term Debt: 997000000.00
CCJ balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 997000000.00
CCJ cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 0.00
CCJ cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -2908000.00
CCJ balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 210972000.00
CCJ balance_sheet (annual, 2022-12-31) — Long Term Provisions: 1022725000.00
CCJ balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 2898317000.00
CCJ balance_sheet (annual, 2022-12-31) — Minority Interest: 11000.00
CCJ income_statement (annual, 2022-12-31) — Minority Interests: 118000.00
CCJ cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -101681000.00
CCJ cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 962917000.00
CCJ balance_sheet (annual, 2022-12-31) — Net Debt: 92326000.00
CCJ cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: -74132000.00
CCJ income_statement (annual, 2022-12-31) — Net Income: 89382000.00
CCJ income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 89382000.00
CCJ income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 89264000.00
CCJ income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 89382000.00
CCJ income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 89382000.00
CCJ cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 89264000.00
CCJ income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 89264000.00
CCJ income_statement (annual, 2022-12-31) — Net Interest Income: -48229000.00
CCJ cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -1044473000.00
CCJ cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -2908000.00
CCJ cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -2908000.00
CCJ income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -48229000.00
CCJ cash_flow (annual, 2022-12-31) — Net Other Investing Changes: -2000000.00
CCJ balance_sheet (annual, 2022-12-31) — Net PPE: 3473490000.00
CCJ cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -142668000.00
CCJ balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 5788937000.00
CCJ balance_sheet (annual, 2022-12-31) — Non Current Accounts Receivable: 595507000.00
CCJ balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 984071000.00
CCJ balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 984071000.00
CCJ income_statement (annual, 2022-12-31) — Normalized EBITDA: 307738000.00
CCJ income_statement (annual, 2022-12-31) — Normalized Income: 72062749.10
CCJ cash_flow (annual, 2022-12-31) — Operating Cash Flow: 304607000.00
CCJ cash_flow (annual, 2022-12-31) — Operating Gains Losses: -84970000.00
CCJ income_statement (annual, 2022-12-31) — Operating Income: 15565000.00
CCJ income_statement (annual, 2022-12-31) — Operating Revenue: 1868003000.00
CCJ balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 432518470.00
CCJ balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 131324000.00
CCJ balance_sheet (annual, 2022-12-31) — Other Equity Interest: 34652000.00
CCJ income_statement (annual, 2022-12-31) — Other Gand A: 172029000.00
CCJ income_statement (annual, 2022-12-31) — Other Income Expense: 117459000.00
CCJ balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 47117000.00
CCJ balance_sheet (annual, 2022-12-31) — Other Inventories: 425000.00
CCJ cash_flow (annual, 2022-12-31) — Other Non Cash Items: 82824000.00
CCJ balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 595507000.00
CCJ balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 216162000.00
CCJ income_statement (annual, 2022-12-31) — Other Operating Expenses: 33522000.00
CCJ balance_sheet (annual, 2022-12-31) — Other Payable: 65182000.00
CCJ balance_sheet (annual, 2022-12-31) — Other Properties: 1565000.00
CCJ balance_sheet (annual, 2022-12-31) — Other Receivables: 42580000.00
CCJ balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 1138174000.00
CCJ balance_sheet (annual, 2022-12-31) — Payables: 381212000.00
CCJ balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 381212000.00
CCJ income_statement (annual, 2022-12-31) — Pretax Income: 84795000.00
CCJ cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 9632000.00
CCJ cash_flow (annual, 2022-12-31) — Purchase Of Business: -101681000.00
CCJ cash_flow (annual, 2022-12-31) — Purchase Of Investment: -1044473000.00
CCJ cash_flow (annual, 2022-12-31) — Purchase Of PPE: -143448000.00
CCJ balance_sheet (annual, 2022-12-31) — Raw Materials: 742039000.00
CCJ balance_sheet (annual, 2022-12-31) — Receivables: 217180000.00
CCJ income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 1634712000.00
CCJ income_statement (annual, 2022-12-31) — Reconciled Depreciation: 177376000.00
CCJ cash_flow (annual, 2022-12-31) — Repayment Of Debt: -2908000.00
CCJ income_statement (annual, 2022-12-31) — Research And Development: 12175000.00
CCJ balance_sheet (annual, 2022-12-31) — Restricted Cash: 239000000.00
CCJ income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: -22802000.00
CCJ balance_sheet (annual, 2022-12-31) — Retained Earnings: 2696379000.00
CCJ cash_flow (annual, 2022-12-31) — Sale Of PPE: 780000.00
CCJ income_statement (annual, 2022-12-31) — Selling General And Administration: 172029000.00
CCJ balance_sheet (annual, 2022-12-31) — Share Issued: 432518470.00
CCJ income_statement (annual, 2022-12-31) — Special Income Charges: 22288000.00
CCJ cash_flow (annual, 2022-12-31) — Stock Based Compensation: 3318000.00
CCJ balance_sheet (annual, 2022-12-31) — Stockholders Equity: 5836054000.00
CCJ balance_sheet (annual, 2022-12-31) — Tangible Book Value: 5788937000.00
CCJ income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 6151749.10
CCJ income_statement (annual, 2022-12-31) — Tax Provision: -4469000.00
CCJ income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.26
CCJ balance_sheet (annual, 2022-12-31) — Taxes Receivable: 6912000.00
CCJ cash_flow (annual, 2022-12-31) — Taxes Refund Paid: -1521000.00
CCJ balance_sheet (annual, 2022-12-31) — Total Assets: 8632793000.00
CCJ balance_sheet (annual, 2022-12-31) — Total Capitalization: 6833054000.00
CCJ balance_sheet (annual, 2022-12-31) — Total Debt: 997000000.00
CCJ balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 5836065000.00
CCJ income_statement (annual, 2022-12-31) — Total Expenses: 1852438000.00
CCJ balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 2796728000.00
CCJ balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 5311157000.00
CCJ balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 2235887000.00
CCJ income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 15051000.00
CCJ income_statement (annual, 2022-12-31) — Total Other Finance Cost: 16690000.00
CCJ balance_sheet (annual, 2022-12-31) — Total Tax Payable: 6498000.00
CCJ income_statement (annual, 2022-12-31) — Total Unusual Items: 23471000.00
CCJ income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 23471000.00
CCJ balance_sheet (annual, 2022-12-31) — Working Capital: 2760795000.00
CCJ income_statement (annual, 2023-12-31) — +Operating Expense: 276617000.00
CCJ income_statement (annual, 2023-12-31) — +Total Revenue: 2587758000.00
CCJ balance_sheet (annual, 2023-12-31) — Accounts Payable: 368847000.00
CCJ balance_sheet (annual, 2023-12-31) — Accounts Receivable: 413792000.00
CCJ balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -6149397000.00
CCJ balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 215679000.00
CCJ income_statement (annual, 2023-12-31) — Basic Average Shares: 433383000.00
CCJ income_statement (annual, 2023-12-31) — Basic EPS: 0.83
CCJ cash_flow (annual, 2023-12-31) — Beginning Cash Position: 1143674000.00
CCJ cash_flow (annual, 2023-12-31) — Capital Expenditure: -153631000.00
CCJ balance_sheet (annual, 2023-12-31) — Capital Stock: 2914165000.00
CCJ balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 566809000.00
CCJ balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 566809000.00
CCJ cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -52079000.00
CCJ cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 748812000.00
CCJ cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -2044852000.00
CCJ cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 688136000.00
CCJ cash_flow (annual, 2023-12-31) — Change In Inventory: 46804000.00
CCJ cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 169044000.00
CCJ cash_flow (annual, 2023-12-31) — Change In Receivables: -242416000.00
CCJ cash_flow (annual, 2023-12-31) — Change In Working Capital: -26568000.00
CCJ cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -242416000.00
CCJ cash_flow (annual, 2023-12-31) — Changes In Cash: -607904000.00
CCJ balance_sheet (annual, 2023-12-31) — Common Stock: 2914165000.00
CCJ cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -52079000.00
CCJ balance_sheet (annual, 2023-12-31) — Common Stock Equity: 6094305000.00
CCJ cash_flow (annual, 2023-12-31) — Common Stock Issuance: 27537000.00
CCJ balance_sheet (annual, 2023-12-31) — Construction In Progress: 237280000.00
CCJ income_statement (annual, 2023-12-31) — Cost Of Revenue: 2026092000.00
CCJ balance_sheet (annual, 2023-12-31) — Current Assets: 1841890000.00
CCJ balance_sheet (annual, 2023-12-31) — Current Debt: 499821000.00
CCJ balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 499821000.00
CCJ balance_sheet (annual, 2023-12-31) — Current Liabilities: 1189104000.00
CCJ balance_sheet (annual, 2023-12-31) — Current Provisions: 39113000.00
CCJ cash_flow (annual, 2023-12-31) — Deferred Income Tax: 126337000.00
CCJ cash_flow (annual, 2023-12-31) — Deferred Tax: 126337000.00
CCJ cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 220324000.00
CCJ cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 220324000.00
CCJ income_statement (annual, 2023-12-31) — Diluted Average Shares: 435355000.00
CCJ income_statement (annual, 2023-12-31) — Diluted EPS: 0.83
CCJ income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 360847000.00
CCJ cash_flow (annual, 2023-12-31) — Dividend Received Cfo: 113642000.00
CCJ balance_sheet (annual, 2023-12-31) — Dueto Related Parties Current: 99847000.00
CCJ income_statement (annual, 2023-12-31) — EBIT: 579198000.00
CCJ income_statement (annual, 2023-12-31) — EBITDA: 799522000.00
CCJ income_statement (annual, 2023-12-31) — Earnings From Equity Interest: 154462000.00
CCJ cash_flow (annual, 2023-12-31) — Earnings Losses From Equity Investments: -154462000.00
CCJ cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 31039000.00
CCJ cash_flow (annual, 2023-12-31) — End Cash Position: 566809000.00
CCJ cash_flow (annual, 2023-12-31) — Financing Cash Flow: 748812000.00
CCJ balance_sheet (annual, 2023-12-31) — Finished Goods: 108711000.00
CCJ cash_flow (annual, 2023-12-31) — Free Cash Flow: 534505000.00
CCJ cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: -61658000.00
CCJ income_statement (annual, 2023-12-31) — Gain On Sale Of Ppe: -2188000.00
CCJ income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 53483000.00
CCJ income_statement (annual, 2023-12-31) — General And Administrative Expense: 245539000.00
CCJ balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 43577000.00
CCJ balance_sheet (annual, 2023-12-31) — Gross PPE: 9518169000.00
CCJ income_statement (annual, 2023-12-31) — Gross Profit: 561666000.00
CCJ income_statement (annual, 2023-12-31) — Interest Expense: 92045000.00
CCJ income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 92045000.00
CCJ income_statement (annual, 2023-12-31) — Interest Income: 111670000.00
CCJ income_statement (annual, 2023-12-31) — Interest Income Non Operating: 111670000.00
CCJ cash_flow (annual, 2023-12-31) — Interest Paid Cff: -40798000.00
CCJ cash_flow (annual, 2023-12-31) — Interest Received Cfo: 113797000.00
CCJ balance_sheet (annual, 2023-12-31) — Inventory: 841613000.00
CCJ balance_sheet (annual, 2023-12-31) — Invested Capital: 7878479000.00
CCJ cash_flow (annual, 2023-12-31) — Investing Cash Flow: -2044852000.00
CCJ balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 613773000.00
CCJ balance_sheet (annual, 2023-12-31) — Investments And Advances: 3173185000.00
CCJ balance_sheet (annual, 2023-12-31) — Investmentsin Associatesat Cost: 273806000.00
CCJ balance_sheet (annual, 2023-12-31) — Investmentsin Joint Venturesat Cost: 2899379000.00
CCJ cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 27537000.00
CCJ cash_flow (annual, 2023-12-31) — Issuance Of Debt: 816582000.00
CCJ balance_sheet (annual, 2023-12-31) — Land And Improvements: 5213324000.00
CCJ balance_sheet (annual, 2023-12-31) — Leases: 8326000.00
CCJ balance_sheet (annual, 2023-12-31) — Long Term Debt: 1284353000.00
CCJ balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 1284353000.00
CCJ cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 816582000.00
CCJ cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -2430000.00
CCJ balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 3173185000.00
CCJ balance_sheet (annual, 2023-12-31) — Long Term Provisions: 1022871000.00
CCJ balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 2990396000.00
CCJ balance_sheet (annual, 2023-12-31) — Minority Interest: 4000.00
CCJ income_statement (annual, 2023-12-31) — Minority Interests: 31000.00
CCJ cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -3028977000.00
CCJ cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 27537000.00
CCJ balance_sheet (annual, 2023-12-31) — Net Debt: 1217365000.00
CCJ cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: -15692000.00
CCJ income_statement (annual, 2023-12-31) — Net Income: 360847000.00
CCJ income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 360847000.00
CCJ income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 360816000.00
CCJ income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 360847000.00
CCJ income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 360847000.00
CCJ cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 360816000.00
CCJ income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 360816000.00
CCJ income_statement (annual, 2023-12-31) — Net Interest Income: -4199000.00
CCJ cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 1136687000.00
CCJ cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 814152000.00
CCJ cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 814152000.00
CCJ income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -4199000.00
CCJ cash_flow (annual, 2023-12-31) — Net Other Investing Changes: 1000000.00
CCJ balance_sheet (annual, 2023-12-31) — Net PPE: 3368772000.00
CCJ cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -153562000.00
CCJ balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 6050728000.00
CCJ balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 892860000.00
CCJ balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 892860000.00
CCJ income_statement (annual, 2023-12-31) — Normalized EBITDA: 748227000.00
CCJ income_statement (annual, 2023-12-31) — Normalized Income: 322854712.73
CCJ cash_flow (annual, 2023-12-31) — Operating Cash Flow: 688136000.00
CCJ cash_flow (annual, 2023-12-31) — Operating Gains Losses: -229624000.00
CCJ income_statement (annual, 2023-12-31) — Operating Income: 285049000.00
CCJ income_statement (annual, 2023-12-31) — Operating Revenue: 2587758000.00
CCJ balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 434175752.00
CCJ balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 499821000.00
CCJ balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 48544000.00
CCJ balance_sheet (annual, 2023-12-31) — Other Equity Interest: -15282000.00
CCJ income_statement (annual, 2023-12-31) — Other Gand A: 245539000.00
CCJ income_statement (annual, 2023-12-31) — Other Income Expense: 206303000.00
CCJ balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 43577000.00
CCJ balance_sheet (annual, 2023-12-31) — Other Inventories: 433000.00
CCJ cash_flow (annual, 2023-12-31) — Other Non Cash Items: -64652000.00
CCJ balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 613773000.00
CCJ balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 343420000.00
CCJ income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 546000.00
CCJ income_statement (annual, 2023-12-31) — Other Operating Expenses: 10042000.00
CCJ balance_sheet (annual, 2023-12-31) — Other Payable: 108856000.00
CCJ balance_sheet (annual, 2023-12-31) — Other Properties: 401000.00
CCJ balance_sheet (annual, 2023-12-31) — Other Receivables: 11930000.00
CCJ balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 0.00
CCJ balance_sheet (annual, 2023-12-31) — Payables: 601626000.00
CCJ balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 601626000.00
CCJ income_statement (annual, 2023-12-31) — Pretax Income: 487153000.00
CCJ cash_flow (annual, 2023-12-31) — Purchase Of Business: -3028977000.00
CCJ cash_flow (annual, 2023-12-31) — Purchase Of PPE: -153631000.00
CCJ balance_sheet (annual, 2023-12-31) — Raw Materials: 732469000.00
CCJ balance_sheet (annual, 2023-12-31) — Receivables: 433468000.00
CCJ income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 2026092000.00
CCJ income_statement (annual, 2023-12-31) — Reconciled Depreciation: 220324000.00
CCJ cash_flow (annual, 2023-12-31) — Repayment Of Debt: -2430000.00
CCJ income_statement (annual, 2023-12-31) — Research And Development: 21036000.00
CCJ balance_sheet (annual, 2023-12-31) — Restricted Cash: 156274000.00
CCJ income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 0.00
CCJ balance_sheet (annual, 2023-12-31) — Retained Earnings: 2979743000.00
CCJ cash_flow (annual, 2023-12-31) — Sale Of PPE: 69000.00
CCJ income_statement (annual, 2023-12-31) — Selling General And Administration: 245539000.00
CCJ balance_sheet (annual, 2023-12-31) — Share Issued: 434175752.00
CCJ income_statement (annual, 2023-12-31) — Special Income Charges: -2188000.00
CCJ cash_flow (annual, 2023-12-31) — Stock Based Compensation: 3692000.00
CCJ balance_sheet (annual, 2023-12-31) — Stockholders Equity: 6094305000.00
CCJ balance_sheet (annual, 2023-12-31) — Tangible Book Value: 6050728000.00
CCJ income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 13302712.73
CCJ income_statement (annual, 2023-12-31) — Tax Provision: 126337000.00
CCJ income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.26
CCJ balance_sheet (annual, 2023-12-31) — Taxes Receivable: 7746000.00
CCJ cash_flow (annual, 2023-12-31) — Taxes Refund Paid: 70372000.00
CCJ balance_sheet (annual, 2023-12-31) — Total Assets: 9934057000.00
CCJ balance_sheet (annual, 2023-12-31) — Total Capitalization: 7378658000.00
CCJ balance_sheet (annual, 2023-12-31) — Total Debt: 1784174000.00
CCJ balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 6094309000.00
CCJ income_statement (annual, 2023-12-31) — Total Expenses: 2302709000.00
CCJ balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 3839748000.00
CCJ balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 8092167000.00
CCJ balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 2650644000.00
CCJ income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 282861000.00
CCJ income_statement (annual, 2023-12-31) — Total Other Finance Cost: 23824000.00
CCJ balance_sheet (annual, 2023-12-31) — Total Tax Payable: 24076000.00
CCJ income_statement (annual, 2023-12-31) — Total Unusual Items: 51295000.00
CCJ income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 51295000.00
CCJ balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
CCJ balance_sheet (annual, 2023-12-31) — Working Capital: 652786000.00
CCJ income_statement (quarterly, 2024-09-30) — Basic Average Shares: 435181000.00
CCJ income_statement (quarterly, 2024-09-30) — Basic EPS: 0.02
CCJ income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 435474000.00
CCJ income_statement (quarterly, 2024-09-30) — Diluted EPS: 0.02
CCJ balance_sheet (quarterly, 2024-09-30) — Investmentsin Associatesat Cost: 238521000.00
CCJ balance_sheet (quarterly, 2024-09-30) — Investmentsin Joint Venturesat Cost: 2747758000.00
CCJ balance_sheet (quarterly, 2024-09-30) — Net Debt: 1102974000.00
CCJ cash_flow (quarterly, 2024-09-30) — Net Investment Purchase And Sale: 0.00
CCJ balance_sheet (quarterly, 2024-09-30) — Restricted Cash: 36596000.00
CCJ cash_flow (quarterly, 2024-09-30) — Sale Of Investment: 0.00
CCJ income_statement (annual, 2024-12-31) — +Operating Expense: 271426000.00
CCJ income_statement (annual, 2024-12-31) — +Total Revenue: 3135772000.00
CCJ balance_sheet (annual, 2024-12-31) — Accounts Payable: 129832000.00
CCJ balance_sheet (annual, 2024-12-31) — Accounts Receivable: 309570000.00
CCJ balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -6454164000.00
CCJ balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -6454164000.00
CCJ balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 210784000.00
CCJ income_statement (annual, 2024-12-31) — Basic Average Shares: 434870000.00
CCJ income_statement (annual, 2024-12-31) — Basic EPS: 0.40
CCJ cash_flow (annual, 2024-12-31) — Beginning Cash Position: 566809000.00
CCJ cash_flow (annual, 2024-12-31) — Capital Expenditure: -211635000.00
CCJ balance_sheet (annual, 2024-12-31) — Capital Stock: 2935367000.00
CCJ balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 600462000.00
CCJ balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 600462000.00
CCJ cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -69641000.00
CCJ cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -688422000.00
CCJ cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -206442000.00
CCJ cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 905288000.00
CCJ cash_flow (annual, 2024-12-31) — Change In Inventory: -111528000.00
CCJ cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 21400000.00
CCJ cash_flow (annual, 2024-12-31) — Change In Receivables: 78562000.00
CCJ cash_flow (annual, 2024-12-31) — Change In Working Capital: -11566000.00
CCJ cash_flow (annual, 2024-12-31) — Changes In Account Receivables: 78562000.00
CCJ cash_flow (annual, 2024-12-31) — Changes In Cash: 10424000.00
CCJ balance_sheet (annual, 2024-12-31) — Common Stock: 2935367000.00
CCJ cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -69641000.00
CCJ balance_sheet (annual, 2024-12-31) — Common Stock Equity: 6364307000.00
CCJ cash_flow (annual, 2024-12-31) — Common Stock Issuance: 16656000.00
CCJ balance_sheet (annual, 2024-12-31) — Construction In Progress: 265665000.00
CCJ balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 265665000.00
CCJ income_statement (annual, 2024-12-31) — Cost Of Revenue: 2353190000.00
CCJ balance_sheet (annual, 2024-12-31) — Current Assets: 1923187000.00
CCJ balance_sheet (annual, 2024-12-31) — Current Debt: 285707000.00
CCJ balance_sheet (quarterly, 2024-12-31) — Current Debt: 285707000.00
CCJ balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 285707000.00
CCJ balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 285707000.00
CCJ balance_sheet (annual, 2024-12-31) — Current Liabilities: 1185761000.00
CCJ balance_sheet (annual, 2024-12-31) — Current Provisions: 37974000.00
CCJ cash_flow (annual, 2024-12-31) — Deferred Income Tax: 84874000.00
CCJ cash_flow (annual, 2024-12-31) — Deferred Tax: 84874000.00
CCJ cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 280702000.00
CCJ cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 280702000.00
CCJ income_statement (annual, 2024-12-31) — Diluted Average Shares: 435956000.00
CCJ income_statement (annual, 2024-12-31) — Diluted EPS: 0.39
CCJ income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 171853000.00
CCJ cash_flow (annual, 2024-12-31) — Dividend Received Cfo: 185447000.00
CCJ balance_sheet (annual, 2024-12-31) — Dueto Related Parties Current: 367559000.00
CCJ balance_sheet (quarterly, 2024-12-31) — Dueto Related Parties Current: 367559000.00
CCJ income_statement (annual, 2024-12-31) — EBIT: 384880000.00
CCJ income_statement (annual, 2024-12-31) — EBITDA: 665582000.00
CCJ income_statement (annual, 2024-12-31) — Earnings From Equity Interest: -10844000.00
CCJ cash_flow (annual, 2024-12-31) — Earnings Losses From Equity Investments: 10844000.00
CCJ cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 23229000.00
CCJ cash_flow (annual, 2024-12-31) — End Cash Position: 600462000.00
CCJ cash_flow (annual, 2024-12-31) — Financing Cash Flow: -688422000.00
CCJ balance_sheet (annual, 2024-12-31) — Finished Goods: 146612000.00
CCJ cash_flow (annual, 2024-12-31) — Free Cash Flow: 693653000.00
CCJ cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 149629000.00
CCJ income_statement (annual, 2024-12-31) — Gain On Sale Of Ppe: -1042000.00
CCJ income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -117586000.00
CCJ income_statement (annual, 2024-12-31) — General And Administrative Expense: 253150000.00
CCJ balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 39822000.00
CCJ balance_sheet (annual, 2024-12-31) — Gross PPE: 9740679000.00
CCJ balance_sheet (quarterly, 2024-12-31) — Gross PPE: 9740679000.00
CCJ income_statement (annual, 2024-12-31) — Gross Profit: 782582000.00
CCJ income_statement (annual, 2024-12-31) — Interest Expense: 128164000.00
CCJ income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 128164000.00
CCJ income_statement (annual, 2024-12-31) — Interest Income: 21228000.00
CCJ income_statement (annual, 2024-12-31) — Interest Income Non Operating: 21228000.00
CCJ cash_flow (annual, 2024-12-31) — Interest Paid Cff: -88818000.00
CCJ cash_flow (annual, 2024-12-31) — Interest Received Cfo: 21228000.00
CCJ balance_sheet (annual, 2024-12-31) — Inventory: 972253000.00
CCJ balance_sheet (annual, 2024-12-31) — Invested Capital: 7359890000.00
CCJ cash_flow (annual, 2024-12-31) — Investing Cash Flow: -206442000.00
CCJ balance_sheet (annual, 2024-12-31) — Investments And Advances: 3218456000.00
CCJ cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 16656000.00
CCJ cash_flow (annual, 2024-12-31) — Issuance Of Debt: 497022000.00
CCJ cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: 0.00
CCJ balance_sheet (annual, 2024-12-31) — Land And Improvements: 5285231000.00
CCJ balance_sheet (quarterly, 2024-12-31) — Land And Improvements: 5285231000.00
CCJ balance_sheet (annual, 2024-12-31) — Leases: 7705000.00
CCJ balance_sheet (quarterly, 2024-12-31) — Leases: 7705000.00
CCJ balance_sheet (annual, 2024-12-31) — Line Of Credit: 285707000.00
CCJ balance_sheet (quarterly, 2024-12-31) — Line Of Credit: 285707000.00
CCJ balance_sheet (annual, 2024-12-31) — Long Term Debt: 995583000.00
CCJ balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 995583000.00
CCJ cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 497022000.00
CCJ cash_flow (quarterly, 2024-12-31) — Long Term Debt Issuance: 0.00
CCJ cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -1043641000.00
CCJ balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 3218456000.00
CCJ balance_sheet (annual, 2024-12-31) — Long Term Provisions: 997833000.00
CCJ balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 3111335000.00
CCJ balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 3111335000.00
CCJ balance_sheet (annual, 2024-12-31) — Minority Interest: 26000.00
CCJ income_statement (annual, 2024-12-31) — Minority Interests: 11000.00
CCJ cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 0.00
CCJ cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 16656000.00
CCJ balance_sheet (annual, 2024-12-31) — Net Debt: 395121000.00
CCJ balance_sheet (quarterly, 2024-12-31) — Net Debt: 395121000.00
CCJ cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: -65517000.00
CCJ income_statement (annual, 2024-12-31) — Net Income: 171853000.00
CCJ income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 171853000.00
CCJ income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 171842000.00
CCJ income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 171853000.00
CCJ income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 171853000.00
CCJ cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 171842000.00
CCJ income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 171842000.00
CCJ income_statement (annual, 2024-12-31) — Net Interest Income: -125943000.00
CCJ cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 0.00
CCJ cash_flow (quarterly, 2024-12-31) — Net Investment Purchase And Sale: 0.00
CCJ cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -546619000.00
CCJ cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -546619000.00
CCJ income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -125943000.00
CCJ cash_flow (annual, 2024-12-31) — Net Other Investing Changes: 4816000.00
CCJ cash_flow (quarterly, 2024-12-31) — Net Other Investing Changes: -2187000.00
CCJ balance_sheet (annual, 2024-12-31) — Net PPE: 3286515000.00
CCJ cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -211258000.00
CCJ balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 6324485000.00
CCJ balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 843131000.00
CCJ balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 843131000.00
CCJ income_statement (annual, 2024-12-31) — Normalized EBITDA: 784210000.00
CCJ income_statement (annual, 2024-12-31) — Normalized Income: 251260877.87
CCJ cash_flow (annual, 2024-12-31) — Operating Cash Flow: 905288000.00
CCJ cash_flow (annual, 2024-12-31) — Operating Gains Losses: 95998000.00
CCJ income_statement (annual, 2024-12-31) — Operating Income: 511156000.00
CCJ income_statement (annual, 2024-12-31) — Operating Revenue: 3135772000.00
CCJ balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 435312083.00
CCJ balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 221820000.00
CCJ balance_sheet (annual, 2024-12-31) — Other Equity Interest: 118892000.00
CCJ income_statement (annual, 2024-12-31) — Other Gand A: 253150000.00
CCJ income_statement (annual, 2024-12-31) — Other Income Expense: -128497000.00
CCJ balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 39822000.00
CCJ balance_sheet (quarterly, 2024-12-31) — Other Intangible Assets: 39822000.00
CCJ balance_sheet (annual, 2024-12-31) — Other Inventories: 458000.00
CCJ cash_flow (annual, 2024-12-31) — Other Non Cash Items: 108474000.00
CCJ balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 595896000.00
CCJ balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 363497000.00
CCJ income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 975000.00
CCJ income_statement (annual, 2024-12-31) — Other Operating Expenses: -18264000.00
CCJ balance_sheet (annual, 2024-12-31) — Other Payable: 121644000.00
CCJ balance_sheet (quarterly, 2024-12-31) — Other Payable: 121644000.00
CCJ balance_sheet (annual, 2024-12-31) — Other Properties: 507000.00
CCJ balance_sheet (quarterly, 2024-12-31) — Other Properties: 507000.00
CCJ balance_sheet (annual, 2024-12-31) — Other Receivables: 9649000.00
CCJ balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 0.00
CCJ balance_sheet (quarterly, 2024-12-31) — Other Short Term Investments: 0.00
CCJ balance_sheet (annual, 2024-12-31) — Payables: 640260000.00
CCJ balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 640260000.00
CCJ income_statement (annual, 2024-12-31) — Pretax Income: 256716000.00
CCJ cash_flow (annual, 2024-12-31) — Purchase Of Business: 0.00
CCJ cash_flow (annual, 2024-12-31) — Purchase Of PPE: -211635000.00
CCJ balance_sheet (annual, 2024-12-31) — Raw Materials: 825183000.00
CCJ balance_sheet (annual, 2024-12-31) — Receivables: 350472000.00
CCJ income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 2353190000.00
CCJ income_statement (annual, 2024-12-31) — Reconciled Depreciation: 280702000.00
CCJ cash_flow (annual, 2024-12-31) — Repayment Of Debt: -1043641000.00
CCJ income_statement (annual, 2024-12-31) — Research And Development: 36540000.00
CCJ balance_sheet (annual, 2024-12-31) — Retained Earnings: 3099264000.00
CCJ cash_flow (annual, 2024-12-31) — Sale Of PPE: 377000.00
CCJ income_statement (annual, 2024-12-31) — Selling General And Administration: 253150000.00
CCJ balance_sheet (annual, 2024-12-31) — Share Issued: 435312083.00
CCJ income_statement (annual, 2024-12-31) — Special Income Charges: -1042000.00
CCJ cash_flow (annual, 2024-12-31) — Stock Based Compensation: 6775000.00
CCJ balance_sheet (annual, 2024-12-31) — Stockholders Equity: 6364307000.00
CCJ balance_sheet (annual, 2024-12-31) — Tangible Book Value: 6324485000.00
CCJ income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -39220122.13
CCJ income_statement (annual, 2024-12-31) — Tax Provision: 84874000.00
CCJ income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.33
CCJ balance_sheet (annual, 2024-12-31) — Taxes Receivable: 31253000.00
CCJ cash_flow (annual, 2024-12-31) — Taxes Refund Paid: -38486000.00
CCJ balance_sheet (annual, 2024-12-31) — Total Assets: 9907007000.00
CCJ balance_sheet (annual, 2024-12-31) — Total Capitalization: 7359890000.00
CCJ balance_sheet (annual, 2024-12-31) — Total Debt: 1281290000.00
CCJ balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 6364333000.00
CCJ income_statement (annual, 2024-12-31) — Total Expenses: 2624616000.00